Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

Clinical trial NCT05380063 · COMPLETED

Trial details

NCT number: NCT05380063
Sponsor: China National Center for Cardiovascular Diseases
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Coronary Artery Bypass Grafting Dual Antiplatelet Therapy Bleeding Myocardial Infarction Myocardial Ischemia Angina Pectoris

Start date: 2023-02-14
Primary completion: 2025-07-08
Enrollment: 2300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.